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ABSTRACT
Nam8, a component of yeast U1 snRNP, is optional
for mitotic growth but required during meiosis,
because Nam8 collaborates with Mer1 to promote
splicing of essential meiotic mRNAs AMA1, MER2
and MER3. Here, we identify SPO22 and PCH2 as
novel targets of Nam8-dependent meiotic splicing.
Whereas SPO22 splicing is co-dependent on Mer1,
PCH2 is not. The SPO22 intron has a non-consensus
50 splice site (50SS) that dictates its Nam8/Mer1-
dependence. SPO22 splicing relies on Mer1 recog-
nition, via its KH domain, of an intronic enhancer
50-AYACCCUY. Mutagenesis of KH and the
enhancer highlights Arg214 and Gln243 and the
CCC triplet as essential for Mer1 activity. The
Nam8-dependent PCH2 pre-mRNA has a consensus
50SS and lacks a Mer1 enhancer. For PCH2, a long
50 exon and a non-consensus intron branchpoint
dictate Nam8-dependence. Our results implicate
Nam8 in two distinct meiotic splicing regulons.
Nam8 is composed of three RRM domains, flanked
by N-terminal leader and C-terminal tail segments.
The leader, tail and RRM1 are dispensable for
splicing meiotic targets and unnecessary for vege-
tative Nam8 function in multiple synthetic lethal
genetic backgrounds. Nam8 activity is enfeebled
by alanine mutations in the putative RNA binding
sites of the RRM2 and RRM3 domains.
INTRODUCTION
Regulated pre-mRNA splicing ﬁgures prominently in the
control of eukaryal gene expression. Alternative splice site
utilization ampliﬁes the information content of the human
genome (1,2), allowing a single transcription unit to
generate multiple protein products that may differ in
their domain composition, cellular localization,
macromolecular interactions or biochemical activities.
Splicing control receives numerous inputs in metazoan or-
ganisms: (i) from cis-acting RNA sequences or secondary
structures that modulate interactions of the splicing ma-
chinery with pre-mRNA (3) and (ii) from a ﬂeet of RNA-
binding proteins (4) that enhance or silence splicing in
response to these RNA signals, to changes in the cellular
milieu, and to developmental cues (2,5,6). Defects or
imbalances in pre-mRNA splicing underlie a broad
spectrum of human diseases, either via mutations of core
splicing machinery and splicing regulatory factors or,
more commonly, mutations of RNA signals that direct
or regulate splice site utilization (7).
Yeast has been a powerful model system to elucidate the
composition and function of the core splicing machinery
(8) and the dynamic changes in the spliceosome that
propel splicing chemistry and ﬁdelity (9). Although
budding yeast has relatively few natural examples of
splicing regulation via alternative 50 splice site choice,
alternative 30 splice site choice or exon skipping (10–12),
it relies heavily in meiosis on controlling the mode of al-
ternative splicing known as intron retention (2). To wit,
the meiotic developmental program entails a shift in the
processing patterns of target pre-mRNAs from a vegeta-
tive ‘off’ state, in which single introns are included, to a
meiotic ‘on’ state in which the target introns are removed.
The discovery of Mer1-regulated meiotic splicing and the
appreciation that Mer1 functions together with Nam8 to
compensate for inherently weak introns are landmarks in
the ﬁeld (13–15).
Nam8 is an RNA-binding component of the yeast U1
snRNP and is present in the commitment complex of U1
snRNP at the 50 splice site, where it can be crosslinked to
the pre-mRNA (16–18). The Nam8 protein contains three
tandem RRM domains and is a putative yeast homolog of
the mammalian RNA-binding protein and pre-mRNA
splicing factor TIA-1 (19,20). Nam8 is inessential for
yeast mitotic growth, but is essential for yeast sporulation
because it promotes splicing of a small set of speciﬁc
mRNAs that encode proteins required for meiotic
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dependent splicing of three meiotic mRNAs – AMA1,
MER2 and MER3 – is activated by the meiotic splicing
regulator Mer1 (13,24). Mer1 is produced only in meiotic
cells under the control of the meiotic transcription factor
Ime1 (25). Mer1 activates splicing by binding to an
intronic splicing enhancer sequence (50-AYACCCUY-30)
present in the AMA1, MER2 and MER3 pre-mRNAs
(15). Mer1 bound to the intronic enhancer is thought to
promote assembly of the U1 and U2 snRNPs on the
pre-mRNA (22,26). Transcripts subject to Mer1/Nam8
splicing regulation have suboptimal 50 splice sites and, in
some cases, suboptimal branchpoints or a large 50 exon
that might, alone or together, dictate their reliance on
otherwise inessential splicing factors (14,22,27).
Recent studies have illuminated additional meiotic
intron-containing genes as potential targets of regulated
splicing, several of which do not contain a Mer1 enhancer
(10,28–31). Here, by evaluating the splicing of the known
meiotic intron-containing RNAs in wild-type and nam8D
yeast diploids during attempted sporulation, we dis-
covered that Nam8 has two additional meiotic mRNAs
targets: SPO22 and PCH2. The SPO22 intron contains
a Mer1 binding site and requires both Nam8 and Mer1
for splicing. By contrast, PCH2 lacks a Mer1 site and is
indifferent to the presence of Mer1 for its splicing. We
interrogated the prevailing hypothesis that meiotic
splicing controllers such as Mer1 and Nam8 compensate
for weak intronic splicing signals and/or override negative
inﬂuences exerted by other RNA elements. We elucidated
these RNA features for SPO22, MER3 and PCH2.A
structure-guided mutational analysis of the putative
RNA binding site of Mer1 identiﬁed individual amino
acid functional groups required for its splicing enhance-
ment activity in vivo. Mutational analysis of Nam8
demarcated domain requirements for meiotic splicing
and for Nam8 function in vegetative cells that require
Nam8 for growth because they lack other inessential
splicing factors.
METHODS
Yeast strains for sporulation studies
The meiosis/sporulation experiments were carried out with
isogenic diploids in the SK1 background. To generate the
nam8 diploids, haploid derivatives of the SK1 strain,
SKY163 (MATa ho::LYS2 lys2 ura3 leu3::hisG) and
SKY164 (MAT ho::LYS2 lys2 ura3 leu3::hisG) were
used. In brief, a DNA segment encompassing the
nam8::kanMX disruption cassette was generated by poly-
merase chain reaction (PCR) ampliﬁcation of genomic
DNA from a nam8::kanMX yeast strain, the PCR
product was introduced into SKY163, and
geneticin-resistant kanMX integrants were selected.
SKY164 was transformed with a nam8::natMX deletion
cassette (32,33) and nourseothricin-resistant natMX inte-
grants were selected. The targeted insertions were con-
ﬁrmed by diagnostic Southern blotting. The SKY
haploids were then mated and homozygous nam8
diploids were selected on YPD agar containing 100mg/
ml nourseothricin (clonNat, Werner BioAgents, Jena)
and 150mg/ml geneticin (Invitrogen).
Sporulation and analysis of meiotic RNA splicing
Single colonies of wild-type and nam8 diploid yeast
strains were patched on agar plates with glycerol as the
carbon source for at least 6h to select for cells with
healthy mitochondria. Cells were streaked on YPD agar
plates and incubated for 3 days at 30 C. Single colonies
were then inoculated into YPD liquid medium and grown
at 30 C to stationary phase (A600 of 6–8). Aliquots were
inoculated into 12.5ml of presporulation medium (0.5%
yeast extract, 1% peptone, 0.67% yeast nitrogen base
(without amino acids), 1% potassium acetate, 0.05M po-
tassium biphthalate (pH 5.5), 0.002% antifoam 204) to
attain an A600 of 0.8. The cultures were incubated for
7h at 30 C and added to 100ml of fresh presporulation
medium to attain an A600 of 0.025. After 16h incubation
at 30 C, the cells were washed twice with 100ml of sporu-
lation medium (2% potassium acetate, 0.001% polypro-
pylene glycol) and resuspended in 15ml of sporulation
medium to attain an A600 of 6. For analysis of meiotic
RNA, 2-ml aliquots of the cultures were withdrawn im-
mediately prior to transfer to sporulation medium and at
4h and 8h post-transfer to sporulation medium. Cells
were harvested by centrifugation and RNA was extracted
from the cells by using the MasterPure Yeast RNA
Puriﬁcation Kit (Epicentre BioTechnologies). The
DNase digestion step in the RNA puriﬁcation protocol
was modiﬁed such that the samples were incubated for
1h with 20U of RNase-free DNase I (New England
Biolabs) to eliminate genomic DNA. First-strand cDNA
was synthesized in reaction mixtures containing 10ng/ml
total RNA, 25ng/ml oligo(dT)12–18 primer, 10U/ml
SuperScript II (Invitrogen), 1 X First Strand Buffer,
10mM DTT and 0.5mM dNTPs. RNA, dNTPs and
primers were preincubated for 5min at 65 C before
quick chilling on ice. DTT and First Strand Buffer were
added, and the mixture was incubated at 42 C for 2min.
Finally, reverse transcriptase was added and the reaction
mixture was incubated at 42 C for 50min and then at
70 C for 15min. The cDNAs for meiotic transcripts were
then PCR-ampliﬁed in 25ml reaction mixtures containing
1X native Pfu buffer, 0.2mM dNTPs, 0.8mM gene-
speciﬁc sense strand primer and 0.8mM5 0-
32P-labeled
gene-speciﬁc antisense strand primer (Supplementary
Table S1), 0.05U/ml Pfu DNA Polymerase (Agilent
Technologies) and 2ml of each cDNA sample. The PCR
cycles (n=31) entailed incubations at 94 C for 30s, 55 C
for 90s, and 72 C for 2min. The RT–PCR products were
analyzed by electrophoresis through 2% native agarose
gels. After electrophoresis, the gels were stained with
ethidium bromide and then dried under vacuum on
DEAE paper. The
32P-labeled PCR products were
visualized by autoradiography and quantiﬁed by
scanning with a Fuji BAS-2500 imager.
Assay of splicing of meiotic RNAs in vegetative cells
A haploid ‘wild-type’ NAM8 yeast strain (MATa NAM8
leu2D ura3D), derived from S288c, and a nam8::kanMX
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pYX212-MER1 (2m URA3 MER1) expressing the MER1
open reading frame under the transcriptional control of
the yeast TPI1 promoter (see below), or with the empty
pYX212 vector. Cells were cotransformed with 2m
plasmids bearing SPO22, MER3 or PCH2 genes as
speciﬁed in the ﬁgure legends. pRS425TPI-SPO22
(2m LEU2 SPO22) carries the intron-containing SPO22
gene driven by the TPI1 promoter. pRS425TPI-MER3
(2m LEU2 MER3) carries the intron-containing MER3
gene driven by the TPI1 promoter. pRS425-PCH2
(2m LEU2 PCH2) bears the intron-containing PCH2
gene (from 540bp upstream of the translation start
codon to 265bp downstream of the stop codon) under
the control of its native promoter. Intron mutants were
generated by two-stage overlap extension PCR with mu-
tagenic primers; the mutated DNAs were inserted into
pRS425. The inserts of all plasmid clones were sequenced
to exclude the acquisition of unwanted mutations during
ampliﬁcation and cloning.
The haploid plasmid-bearing yeast strains were grown
in SD-(Ura
 Leu
 ) liquid medium at 30 C until A600
reached 2–4. Cells were harvested by centrifugation from
2-ml aliquots of the cultures. RNA extractions and reverse
transcription–polymerase chain reaction (RT–PCR) were
performed as described above, with exceptions as follows:
(i) cDNA synthesis was primed with 0.1mM gene-speciﬁc
antisense primers (Supplementary Table S1) instead of
oligo(dT)12–18; (ii) the numbers of PCR cycles for ampli-
ﬁcation of MER2, PCH2, SPO22 and MER3 cDNAs
were 28, 27, 25 and 23, respectively; (iii) the PCR reactions
were quenched by adding EDTA and SDS to a ﬁnal con-
centrations of 12.5mM and 3.3%, respectively; and (iv)
the
32P-labeled PCR products were analyzed by electro-
phoresis through native 5% polyacrylamide gels contain-
ing 90mM Tris-borate, 1.2mM EDTA.
Mer1 mutants
The MER1 open reading frame was ampliﬁed by PCR
from yeast genomic DNA using primers designed to
introduce an EcoRI site immediately upstream of the
translation initiation codon and an XhoI site immediately
downstream of the stop codon. The PCR product was
inserted into yeast expression vector pYX212
(2m URA3) to yield pYX212-MER1. Truncated MER1-
ND alleles were constructed by PCR ampliﬁcation of
pYX212-MER1 template with sense-strand primers that
introduced a new start codon at the positions speciﬁed
plus a ﬂanking EcoRI site. Missense mutations were
introduced into the MER1 ORF via a two-stage overlap
extension PCR. The PCR products of the truncated and
mutated MER1 ORFs were digested with EcoRI and
XhoI and inserted into EcoRI/XhoI-cut pYX212-MER1
in lieu of the wild-type gene.
Yeast Nam8 expression vectors
To construct the NAM8 vectors for plasmid shufﬂe com-
plementation assays, a 1.6-bp DNA fragment comprising
the NAM8 ORF plus 427bp of upstream (50) and 277bp
of downstream (30) chromosomal DNA was ampliﬁed by
PCR from Saccharomyces cerevisiae genomic DNA using
primers that introduced a HindIII site at the 50 end and a
SacI site at the 30 end. We then used overlap extension
PCR to introduce a PstI site immediately upstream of
the NAM8 translation initiation codon and an XbaI site
immediately downstream of the stop codon. The NAM8
cassette (ORF plus ﬂanking DNA) was then inserted into
yeast expression vector pRS415 (CEN LEU2) to yield
pRS415-NAM8. The truncated NAM8 alleles were con-
structed by PCR ampliﬁcation with: (i) sense strand
primers that introduced a new start codon at the positions
speciﬁed plus a ﬂanking PstI site and (ii) antisense strand
primers that introduced a new stop codon after the pos-
itions speciﬁed plus a ﬂanking XbaI site. Missense muta-
tions were introduced into the NAM8 ORF via two-stage
overlap extension PCR. The PCR products containing the
truncated and mutated NAM8 ORFs were digested with
PstI and XbaI and inserted into PstI/XbaI-cut pRS415-
NAM8 in lieu of the wild-type gene.
To construct vectors for NAM8 overexpression, the
NAM8 ORFs encoding wild-type, truncated or mutated
Nam8 were ampliﬁed by PCR from their respective
pRS415 plasmids using sense primers that introduced a
KpnI site immediately ﬂanking the start codon. The
PCR products were digested with KpnI/XbaI and
inserted into KpnI/XbaI-cut pYES2 (2m URA3 GAL)s o
as to place NAM8 under the transcriptional control of a
glucose-repressible/galactose-inducible GAL1 promoter.
All of the NAM8 plasmid inserts were sequenced com-
pletely to exclude the acquisition of unwanted mutations
during ampliﬁcation and cloning.
Yeast strains for assays of Nam8 function in vegetative
cells
Saccharomyces cerevisiae strain yTN (Mata tgs1D nam8D
p360-TGS1), described in Hausmann et al. (32) was used
for plasmid shufﬂe complementation assays of Nam8
function. We constructed other nam8D double mutant
strains by crossing and dissecting haploid strains that
were described previously (32,33). In brief, haploid
nam8::natR cells were mixed with lea1::kanMX,
mud1::kanMX and mud2::kanMX cells of the opposite
mating type, and diploids were selected on YPD agar con-
taining nourseothricin and geneticin. The heterozygous
diploids were transformed with a URA3 CEN plasmid
carrying the NAM8 gene. Sporulation was induced and
tetrads were dissected. Individual spores were tested to
select for nam8D::natR mud1D::kanMX p360-NAM8,
nam8D::natR mud2D::kanMX p360-NAM8 or
nam8D::natR lea1D::kanMX p360-NAM8 cells. Using
the same strategy, we also generated nam8D::natR
mud2D::kanMX p360-MUD2, in which the complement-
ing URA3 plasmid harbors the MUD2 gene (33).
HIS3 reporter assay for PCH2 intron splicing
To generate integration cassettes for the HIS3 reporter
genes, a 1-bp genomic DNA fragment spanning the
HIS3 ORF plus 297 and 20bp of upstream and down-
stream sequences was ampliﬁed by PCR using primers
His3-F and His3-R (Supplementary Table S2) and
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insert the PCH2 intron (or the mutated PCH2-BP intron)
at position 430 in the HIS3 ORF, we individually
ampliﬁed the HIS3-50 gene fragment (727bp) with
primers His3-F and exon1R (Supplementary Table S2)
and the HIS3-30 (253bp) gene fragment with His3-R and
exon2F (Table S2). The PCH2 and PCH2-BP introns
(123bp) were ampliﬁed by PCR with primers IntronF
and IntronR. The exon and intron DNA fragments with
overlapping terminal sequences were then assembled into
intron-punctuated HIS3 cassettes by overlap-extension
PCR and the cassettes were inserted into pUC19
plasmids. The HIS3, HIS3-[PCH2] and HIS3-
[PCH2-BP] cassettes were excised with SmaI and PstI
and transformed into nam8D::natR p360-NAM8 (URA3
NAM8) cells and isogenic wild-type cells (harboring a
URA3 plasmid) that were histidine-auxotrophs.
His
+Ura
+ transformants were selected and analyzed for
integration of the respective cassettes at the HIS3 locus
by diagnostic Southern blotting and by sequencing of
PCR-generated DNA fragments using primers designed
to amplify the HIS3 gene. The cells were then streaked
to medium containing 5-FOA (and histidine) to select
for cells that had lost the URA3 plasmids. Individual
colonies were patched to YPD agar. Cells were grown in
liquid YPD medium until the cultures attained A600
between 0.7 and 0.9. The cultures were diluted in water
to A600 of 0.01. Serial 10-fold dilutions were prepared and
aliquots (3ml) of each were spotted in parallel on YPD
agar and SD agar medium lacking histidine.
RESULTS
Meiotic splicing in nam8" cells
RNA was isolated from wild-type and nam8 diploids
immediately prior to (time 0) and 4h and 8h after
transfer from pre-sporulation medium to sporulation
medium. cDNA was prepared from each RNA sample by
RT and then used for gene-speciﬁc PCR ampliﬁcation of
meiotic spliced transcripts (Figure 1 and Table 1). The
sense and antisense primers corresponded to sequences
ﬂanking the introns so that the longer products of ampliﬁ-
cation of cDNA derived from unspliced pre-mRNAs
could be easily resolved by native gel electrophoresis
from the shorter products of ampliﬁcation of cDNAs
copied from spliced mRNA (Figure 1). One of the
primers was 50 32P-labeled in each PCR reaction so that
we could quantify the distributions of unspliced and
spliced cDNAs for each gene of interest (Figure 1, lanes
3–5). An aliquot of a PCR ampliﬁcation reaction using
genomic DNA as template provided a marker for the
unspliced species (lane 2). No labeled products were
generated from PCR reactions programmed by RNA that
had not been subjected to prior treatment with reverse
transcriptase (lane 1), indicating that the RNA samples
were effectively free of contaminating genomic DNA.
Figure 1 shows exemplary data demonstrating induc-
tion of meiotic transcription and regulated meiotic
splicing in wild-type cells, while focusing on some of the
meiotic transcripts for which splicing efﬁciency was most
acutely affected by the absence of Nam8. Transcriptional
induction of the MER3 gene in wild-type cells was evinced
by the increase in total RT–PCR products at 4 and 8h
post-sporulation (lanes 4 and 5) compared to the level at
time 0 (lane 3), which was accompanied by a sharp
increase in the percentage of the RT–PCR product
derived from spliced versus unspliced MER3 RNA. In
agreement with previous studies (34,35), we also
observed transcriptional induction of SPO22 and PCH2
(Figure 1) and of several other intron-containing meiotic
genes analyzed (data not shown). Transcriptional induc-
tion of MER3, SPO22, PCH2 and other meiotic genes was
also evident in nam8 cells after 4 and 8h in sporulation
medium (Figure 1 and data not shown).
The role of Nam8 in meiotic splicing was veriﬁed for
MER3 (one of three known Mer1/Nam8 targets), splicing
of which was barely detectable in nam8 cells at either 4
or 8h (Figure 1). Nam8 was also required for meiotic
splicing of SPO22 and PCH2 pre-mRNAs (Figure 1),
which are hereby identiﬁed as new Nam8 targets. By
contrast, the control GLC7 RNA was constitutively ex-
pressed and very efﬁciently spliced in wild-type cells
( 98% of the RT–PCR product was from spliced GLC7
RNA) and this was unaffected by nam8 (Figure 1).
The results of our survey of splicing of 14 meiotic tran-
scripts at 4h post-induction of sporulation are compiled in
Table 1, wherein each datum for splicing efﬁciency –
[spliced/(spliced + unspliced)] 100 – is the average of
three independent sporulation experiments and RT–PCR
analyses. The absence of Nam8 severely affected meiotic
splicing of AMA1, MER2 and MER3 (the three Nam8
targets described previously) plus novel targets SPO22
and PCH2. Nam8 ablation had little or no impact on
the efﬁciency of splicing of the HOP2, REC114, MEI4,
REC102, DMC1, SPO1, MND1 and SRC1 transcripts
(Table 1), though nam8 did reduce SAE3 splicing
modestly.
Inspection of the features of the 14 meiotically spliced
transcripts reveals that four of them—AMA1, MER2,
MER3 and SPO22—have a Mer1 intronic enhancer,
thereby extending the correlation of coregulation by
Mer1 and Nam8 to the SPO22 pre-mRNA identiﬁed pres-
ently as Nam8 dependent. The magnitudes of the nam8
splicing defects for the four Mer1 enhancer-containing
transcripts were between 12- and 40-fold (Table 1). To
our knowledge, PCH2 is the ﬁrst instance of a Nam8-
dependent meiotic pre-mRNA that does not have a
Mer1 intronic consensus sequence. The decrement in
PCH2 splicing in the nam8 strain was 8-fold.
Differential requirements for Mer1 in splicing of SPO22
and PCH2 mRNAs
Regulated splicing of Mer1-dependent meiotic mRNAs
can be recapitulated in vegetative yeast cells by forced
expression of the Mer1 splicing enhancer protein
(13,15.23). The efﬁcacy of this maneuver is readily
demonstrated for splicing of the MER2 pre-mRNA,
which is constitutively transcribed in vegetative cells, but
is spliced inefﬁciently (20%) because Mer1 is absent
(Figure 2A). Expression of Mer1 during vegetative
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under the control of a constitutive promoter) increased
MER2 splicing efﬁciency to 87% (Figure 2A). MER2
splicing was inhibited severely (5% efﬁciency) in nam8
cells expressing Mer1 (Figure 2A).
To test whether SPO22 or PCH2 pre-mRNA splicing
relies on Mer1, we transformed vegetative cells with 2m
plasmids bearing SPO22 or PCH2 genes plus a second
plasmid for constitutive MER1 expression (or an empty
vector control). Splicing of SPO22 mRNA was acutely
dependent on Mer1 (86% in Mer1-expressing cells
versus 14% in control cells) and Nam8 (4% splicing in
Mer1-expressing nam8cells) (Figure 2B). By contrast,
splicing of PCH2 (at 67% efﬁciency in wild-type vegeta-
tive cells, comparable to that seen in meiotic cells; Table 1)
was unaffected by Mer1 expression (Figure 2C). These
results consolidate the following points: (i) SPO22,
which contains an intronic Mer1 enhancer element, joins
three other meiotic genes—AMA1, MER2 and MER3—to
comprise a splicing regulon controlled by both Mer1 and
Nam8; (ii) PCH2 is the ﬁrst instance of a Mer1-
independent Nam8-regulated meiotic transcript.
Why does SPO22 splicing depend on Mer1 and Nam8?
SPO22 has a consensus Mer1 enhancer element (50-AUAC
CCUU) situated between the 50 splice site and the
branchpoint (Figure 3A). SPO22 is especially interesting,
vis a` vis other Mer1 targets, in that its intron has multiple
features that could confer feeble splicing and hence
reliance on upregulation. These include: (i) a rare non-
consensus 50 splice site (GUAUAU) distinct from those
in other Mer1-dependent transcripts; (ii) a rare non-
consensus branchpoint (AACUAAC); and (iii) a non-
consensus 30 splice site (AAG) (Figure 3A). Analysis
of the SPO22 intron in Mfold (36) revealed no stable
secondary structure that would mask any of these signals.
We installed consensus 50SS, BP and 30SS elements in
the SPO22 gene and tested these SPO22 mutants on 2m
plasmids for their splicing efﬁciency in vegetative
wild-type and nam8 cells that do or do not express
Mer1. Our aim here was to pinpoint which of the intron
manipulations might render SPO22 splicing independent
of Mer1 and/or Nam8. In particular, we wished to see if
the degrees of Nam8 and Mer1 dependence tracked
together, or if we could ﬁnd an intronic manipulation
that dissociated Mer1 from Nam8 (e.g. relieving the re-
quirement for one factor, but not the other). The SPO22
splicing efﬁciencies are plotted in Figure 3A, with each
datum representing the average of three separate
experiments±SEM.
Figure 1. Meiotic splicing in wild-type and nam8 yeast cells. RNAs
isolated from wild-type and nam8D diploid strains sampled immediately
prior to transfer to sporulation medium (lane 3) or 4h (lane 4) and 8h
(lane 5) post-transfer to sporulation medium were reverse transcribed
and the cDNAs were PCR-ampliﬁed with gene-speciﬁc primers ﬂanking
the introns of meiotic transcripts MER3, PCH2, SPO22 and SAE3 and
the constitutively spliced GLC7 transcript. The antisense PCR primers
were 50 32P-labeled in each case. The labeled PCR products were
resolved by native agarose gel electrophoresis and visualized by auto-
radiography. The RNA samples in lane 1 were PCR-ampliﬁed without
reverse transcription, as a control for potential genomic DNA contam-
ination. Lane 2 includes aliquots of the products of PCR-ampliﬁcation
of genomic DNA, which are the same sizes as the RT–PCR products
derived from the intron-containing RNAs. The positions of the RT–
PCR products of unspliced and spliced transcripts are indicated at
‘right’.
Table 1. Meiotic mRNA splicing efﬁciency: effects of nam8
RNA Percent spliced at 4h
WT nam8D
AMA1 84±5 6±3
MER2 (REC107) 76±2 6± 3
MER3 (HFM1) 80±2 2±1
HOP2 88±6 84±4
REC114 87±1 76±2
MEI4 80±1 71±2
REC102 84±4 74±4
DMC1 95±1 95±3
PCH2 73±2 9±2
SAE3 66±1 37±2
SPO1 84±3 80± 4
SPO22 86±1 4±2
MND1 90±4 82±3
SRC1 94±2 87±2
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site (via a single A-to-G change in mutant SPO22-50SS)
eliminated the dependence of SPO22 splicing on Mer1, i.e.
basal splicing efﬁciency was increased to 92% in wild-type
yeast lacking Mer1 and this value was unaffected by Mer1
expression (Figure 3A). Similarly, the consensus 50SS
change effaced the dependence of SPO22 splicing on
Nam8, elevating splicing efﬁciency to 86% in nam8
cells lacking Mer1 (Figure 3A). We surmise that the
nonconsensus 50 splice site is the critical determinant of
the Mer1/Nam8 requirement for efﬁcient SPO22 splicing
in vivo.
By contrast, whereas the installation of a consensus
branchpoint (entailing a A-to-U mutation in SPO22-BP)
or a consensus 30 splice site (UAG in SPO22-30SS) raised
basal splicing efﬁciency in wild-type cells to 51% and
28%, respectively (versus 14% for native SPO22), the
SPO22-BP and SPO22-30SS transcripts remained depend-
ent on Mer1 to attain their optimal splicing efﬁciencies of
86% and 90%, respectively (Figure 3A). The increases in
basal splicing in nam8cells for the SPO22-BP and
SPO22-30SS mutants (to 28% and 16%, respectively,
versus 6% for the native SPO22 transcript) were of
lesser magnitude than that seen in NAM8 cells.
Moreover, there was no further increase in splicing of
the SPO22-BP and SPO22-30SS mutants in nam8 cells
attendant on Mer1 expression (Figure 3A). These results
indicate that: (i) all of the salutary effects of Mer1 on
SPO22 splicing are mediated via Nam8, but not vice
versa; (ii) even in the absence of Mer1, Nam8 has a
modest positive effect ( 2-fold stimulation) on basal
SPO22 splicing, be it in the context of the feebly spliced
native SPO22 intron or the better-spliced consensus BP
and 30SS variants; and (iii) the non-consensus branchpoint
and 30 splice site of SPO22 each exerts a suppressive effect
on intron removal that is ‘independent’ of Nam8, with the
non-consensus branchpoint effect being of greater
magnitude.
Determinants of MER3 pre-mRNA splicing
Inspection of the MER3 intron, which requires Mer1 and
Nam8 for splicing in meiosis (35), reveals several features
not found in other Mer1/Nam8 targets. These include: (i)
a deviant 50SS (GUAGUA) found in no other yeast
introns (37,38); (ii) a rare non-consensus branchpoint
(GACUAAC); (iii) an exceptionally long distance (83-nt)
from the BP to the 30SS (38); and (iv) a 12-nt
polypyrimidine tract (50-CCUCUUUCUUUU) between
the BP and 30SS, placed close to the branchpoint
Figure 2. Nam8 and Mer1 requirements for splicing of meiotic SPO22 and PCH2 mRNAs can be gauged in vegetative cells. Endogenous MER2
transcripts (A) and transcripts derived from plasmid-borne meiotic genes SPO22 (B) and PCH2 (C) were analyzed by RT–PCR with gene-speciﬁc
primers using total RNA template isolated from wild-type or nam8D haploids that carried either a 2m plasmid for constitutive expression of Mer1
(MER1
+) or an empty 2m plasmid control (MER1
 ). The antisense PCR primers were 50 32P-labeled in each case. The PCR products were analyzed
by 5% native PAGE and visualized by autoradiography of the dried gels (A and B, top panels). The RT–PCR products derived from unspliced and
spliced transcripts were quantiﬁed and the splicing efﬁciencies (percentage spliced=spliced /(spliced+unspliced) 100) are plotted (A and B, bottom
panels; C). Each datum is the average of three separate experiments±SEM.
3432 Nucleic Acids Research, 2011,Vol.39, No. 8Figure 3. Intronic determinants of the Nam8 and Mer1 dependence of SPO22 and MER3 pre-mRNA splicing. (A) The nucleotide sequence of the
SPO22 intron is shown, highlighting its nonconsensus 50 splice site, branchpoint and 30 splice site, and the location of its putative Mer1 enhancer.
Base pairing interactions with U1 snRNA at the 50 splice site and with U2 snRNA at the branchpoint are shown. The point mutations (50SS, BP and
30SS) that we introduced into the SPO22 intron are indicated. Splicing was gauged by RT–PCR with SPO22-speciﬁc primers using total RNA
template isolated from wild-type (NAM8)o rnam8D haploids that had been transformed with 2m SPO22 or its intron mutant variants as speciﬁed
plus a 2m plasmid for constitutive expression of Mer1 (MER1
+) or an empty 2mplasmid control (MER1
 ). The antisense PCR primers were 50
32P-labeled in each case. The RT–PCR products derived from unspliced and spliced transcripts were resolved by native 5% PAGE and quantiﬁed.
The splicing efﬁciencies are plotted for the NAM8 and nam8 strains. Each datum is the average of three separate experiments±SEM. (B) The
nucleotide sequence of the MER3 intron is shown, highlighting its nonconsensus 50 splice site and branchpoint, and the location of its putative Mer1
enhancer. The point mutations (50SS and BP) that we introduced into the MER3 intron are indicated. Splicing was gauged by RT–PCR with MER3-
speciﬁc primers using total RNA template isolated from wild-type (NAM8)o rnam8D haploids that had been transformed with 2m MER3 or its
intron mutant variants as speciﬁed plus a 2m plasmid for constitutive expression of Mer1 (MER1
+) or an empty 2mplasmid control (MER1
 ). The
splicing efﬁciencies are plotted for the NAM8 and nam8 strains. Each datum is the average of three separate experiments±SEM.
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splice site that is utilized to generate the correctly spliced
MER3 mRNA that encodes the 1187-aa Mer3 polypeptide
(Figure 3B). MER3 also has three other YAG triplets (po-
tential 30 splice sites) located between the branchpoint/
polypyrimidine tract and the correct 30SS (Figure 3B);
utilization of any of these alternative 30SS would
generate out-of-frame transcripts with premature stop
codons.
We initiated an analysis of MER3 splicing requirements
by installing consensus 50SS and BP signals in the MER3
gene, singly and in combination. Native and mutated
MER3 alleles on 2mplasmids were then assayed by RT–
PCR for their splicing efﬁciency in vegetative wild-type
and nam8 cells that do or do not express Mer1.
Splicing of native MER3 mRNA was dependent on
Mer1 (53% in Mer1-expressing cells versus 3% in
control cells) and Nam8 (2% splicing in Mer1-expressing
nam8cells) (Figure 3B). Introducing a perfect
GUAUGU 50 splice site (via a single U insertion in
mutant MER3-50SS) increased basal splicing efﬁciency
to 75% in wild-type yeast lacking Mer1, and enhanced
the extent of splicing in the presence of Mer1 to 84%
(Figure 3B). By contrast, the consensus BP change per
se elicited a relatively modest elevation in basal MER3
splicing (to 12%) while the MER3-BP intron remained
Mer1-dependent, with splicing efﬁciency rising to 71%
in wild-type cells expressing Mer1 (Figure 3B). The
effects of combining the MER3 50SS and BP changes
(resulting in 78% and 86% splicing in the absence and
presence of Mer1, respectively) were virtually identical to
those seen for the single 50SS change (Figure 3B). These
results signify that the aberrant MER3 50 splice site is the
principal determinant of the Mer1 requirement for
splicing in vivo.
The 50SS change eliminated the dependence of MER3
splicing on Nam8, elevating splicing efﬁciency to 83% in
nam8 cells lacking Mer1 (Figure 3B). The consensus BP
change conferred no such beneﬁt per se (6% splicing with
or without Mer1) and had no additive effects in nam8D
cells when combined with the consensus 50SS mutation
(Figure 3B). We surmise that the weak 50 splice site
is the critical determinant of the Nam8 requirement for
efﬁcient MER3 splicing.
Requirements for Mer1 enhancer elements in the MER3
and SPO22 introns
Spingola and Ares (15) identiﬁed a cis-acting intronic
splicing enhancer, of consensus sequence 50-
AYACCCUY, located within 25-nt of the 50 splice site
in three of the Mer1-responsive meiotic transcripts:
AMA1, MER2 and MER3. Focusing on the AMA1
intron, they showed that multi-base substitutions within
the enhancer element abolished Mer1 splicing activation
without affecting the basal level of splicing in vegetative
cells not expressing Mer1 (15). Here, we conducted a mu-
tational analysis of the corresponding Mer1 enhancer
elements in the MER3 and SPO22 introns. First, the in-
variant central CCC triplets in the putative enhancers of
the MER3 and SPO22 transcripts were changed to GGG.
In both cases, this maneuver abolished Mer1-activated
splicing (Figure 4A and B). We then proceeded to
conduct a ﬁner analysis of the SPO22 intronic enhancer,
by replacing the conserved cytidines singly with guano-
sine. The GCC and CGC variants of SPO22 were unre-
sponsive to Mer1; their splicing efﬁciencies in the presence
of Mer1 (24% and 26%, respectively) were little better
than that of wild-type SPO22 in the absence of Mer1
(18%) (Figure 4C). The SPO22-CCG variant was partially
responsive to Mer1, attaining 41% splicing efﬁciency in
Mer1-expressing cells, versus 88% for the wild-type
SPO22 control (Figure 4C).
To better deﬁne structure-activity relations in the
SPO22 enhancer, the central cytidines were replaced
with uridines, singly and en masse (Figure 4D). The
SPO22-UUU mutant was spliced with 45% splicing efﬁ-
ciency in Mer1-expressing cells, versus 86% for the
wild-type SPO22 control (Figure 4D). The triple C-to-U
change was clearly less deleterious than the triple C-to-G
mutation (Figure 4B). Virtually all of the impact of the
UUU mutation could be attributed to the change in the
ﬁrst pyrimidine position, insofar as the UCC variant (52%
splicing) resembled UUU, whereas the single changes as
the second and third positions had no apparent effect on
the extents of SPO22 splicing in cells expressing Mer1
(85% and 89% for the CUC and CCU variants, respect-
ively) (Figure 4D).
Effects of Mer1 mutations
Saccharomyces cerevisiae Mer1 is a 270-aa polypeptide
composed of two functional modules: a C-terminal KH
domain implicated in RNA binding and an N-terminal
domain that interacts with the spliceosome and
promotes splicing of target mRNAs (22). The KH
domain is an ancient protein fold, widely distributed
among taxa, that binds single-stranded RNA or DNA
(39). KH domains of the type found in Mer1 consist of
a three-stranded antiparallel b sheet plus three a-helices
packed against one face of the sheet (Figure 5A, top
panel). Fenn et al. (40) solved the 1.6A ˚ crystal structure
of a KH domain from the human poly(C)-binding protein
PCBP2 in complex with a 7-nt single-stranded DNA oligo-
nucleotide that included the internal pentamer sequence
50-ACCCT, which is the DNA counterpart of the Mer1
RNA enhancer sequence 50-ACCCU. Reference to the
PCBP2–ssDNA complex shows that recognition of the
pyrimidine-rich sequence is achieved, in large part, via
direct and water-mediated hydrogen bonding interactions
of KH amino acid side chains with the polar edge atoms of
the T and C nucleobases (Figure 5A, top panel). The four
side chains that engage the bases in PCBP2 emanate from
the b2 and b3 strands and the a2 helix. Three of these
pyrimidine-binding residues are conserved in yeast Mer1
(as Arg209, Arg214 and Lys222); the fourth residue, an
arginine in PCBP2, is replaced by glutamine in the yeast
Mer1 and homologous KH domains found in several
other fungal proteomes (Figure 5A, bottom panel).
Guided by the PCBP2 structure, we introduced alanine
mutations in lieu of Mer1 residues Arg209, Arg214,
Lys222 and Gln243 and tested the mutant alleles for
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vegetative yeast cells (Figure 5B). Whereas R209A and
K222A were as active as wild-type MER1 in promoting
SPO22 intron removal (82–84% spliced), the R214A and
Q243A mutants were nonfunctional. The 16% SPO22
splicing seen in MER1-R214A and MER1-Q234A cells
was little better than the 13% SPO22 splicing in yeast
cells that did not express Mer1 (Figure 5B, top panel).
Structure-activity relations in the Mer1 KH domain
were garnered by introducing conservative substitutions
for the essential Arg214 and Gln243 side chains,
whereby Arg214 was changed to lysine and glutamine
and Gln243 was changed to asparagine, glutamate and
arginine (arginine being the native residue at the equiva-
lent position in PCBP2). We found that whereas the
R214K change revived SPO22 splicing activity to the
level of wild-type MER1, the R214Q mutant was no
better than R214A (Figure 5B, bottom panel). We
surmise that a positively charged side chain at position
214 of the KH domain is necessary for Mer1 activity.
The Q243E change elicited a signiﬁcant, though incom-
plete recovery of Mer1 function (to 69% SPO22 splicing
versus 87% for wild-type MER1) that contrasted with the
Q243N and Q243R mutations (22% and 16% SPO22
splicing respectively, which were similar to the 18%
splicing efﬁciency in control cells that did not express
Mer1) (Figure 5B, bottom panel). We conclude that: (i)
a critical distance is required from the protein main chain
to the Gln243 amide (i.e. the shorter Asn residue does not
sufﬁce); (ii) the putative RNA contacts made by Gln243
differ from those made by the corresponding arginine in
the human PCBP2–DNA complex, insofar as a basic
arginine side chain was inactive in Mer1, though an
acidic glutamate residue functioned almost as well as the
native glutamine.
The MER1 mutants were also surveyed for their activity
in promoting the splicing of a different meiotic mRNA
target—MER2 (Figure 5C). The results agreed with the
ﬁndings for SPO22, to wit: (i) Arg209 and Lys222 were
not important for MER2 splicing, but Arg214 and Gln243
were essential; and (ii) R214K and Q243E restored activity
in MER2 splicing, though the other conservative changes
did not.
Determinants of the Nam8-dependence of PCH2 splicing
Unlike the Mer1-regulated Nam8-dependent transcripts,
the PCH2 pre-mRNA has a perfect consensus 50 splice
site and lacks a Mer1 intronic enhancer sequence.
Rather, the PCH2 transcript is distinguished by its
exceptionally long 50 exonic open reading frame
(1551-nt) and a non-consensus intron branchpoint
sequence, 50-CACUAAC (Figure 6). We probed the
PCH2 splicing determinants by: (i) installing a consensus
branchpoint sequence in an otherwise native PCH2 gene;
(ii) deleting most of the long upstream exon (while install-
ing a new in-frame AUG codon) to create a PCH2-D50
variant with a 51-nt 50 exon; and (iii) combining the BP
and D50exon changes. We tested the PCH2 mutants on
2mplasmids for their splicing efﬁciency in NAM8 and
nam8 yeast cells. The results implicate the non-consensus
branchpoint and long 50 exon as separate negative inﬂu-
ences on PCH2 splicing in wild-type cells. For example,
shortening the 50 exon per se increased splicing efﬁciency
to 89% for PCH2-Dexon versus 70% for the PCH2
transcript (Figure 6). The consensus branchpoint change
per se increased splicing efﬁciency to 91% for PCH2-BP
(Figure 6). There was no apparent effect of combining
the BP and Dexon changes in wild-type cells. The PCH2
transcript was spliced with 22% efﬁciency in nam8D cells,
a 3-fold decrement compared to wild-type cells. The
PCH2-Dexon transcript was spliced at 83% efﬁciency in
nam8 cells, signifying that shortening the 50 exon sufﬁced
to override the Nam8 requirement. The PCH2-BP tran-
script was spliced with 63% efﬁciency in nam8D cells,
implying that the nonconsensus branchpoint is an inde-
pendent determinant of Nam8-dependence of PCH2
splicing, albeit perhaps not as strong a factor as 50 exon
length. Combining the BP and exon changes elicited a
further gain of splicing in nam8D cells to 92% (Figure 6).
Nam8 is a stable component of the U1 snRNP and can
be crosslinked to intronic RNA ﬂanking the 50 splice site
(16–18), though the sites of RNA contact within Nam8
Figure 4. Effects of guanosine and uridine substitutions in the putative Mer1 enhancer elements of the MER3 and SPO22 introns. Splicing was
gauged by RT–PCR with MER3 or SPO22-speciﬁc primers using total RNA template isolated from wild-type haploids that had been transformed
with 2m MER3 (A), 2m SPO22 (B–D), or their intronic enhancer mutant variants as speciﬁed plus a 2m plasmid for constitutive expression of Mer1
(MER1
+) or an empty 2mplasmid control (MER1–). The splicing efﬁciencies are plotted. Each datum is the average of three separate
experiments±SEM.
Nucleic Acids Research,2011, Vol.39, No. 8 3435Figure 5. Structure-guided mutational analysis of the Mer1 KH domain. (A) (Top) Stereo view of the crystal structure of the KH domain of human
PCBP2 bound to a single-stranded DNA oligonucleotide, 50-ACCCT (pdb id: 2P2R). Side chain hydrogen bonds to the nucleobases are denoted by
dashed lines. Waters are rendered as red spheres. The amino acid numbering refers to the equivalent position in the KH domain of yeast Mer1.
(Bottom) The primary structure of the S. cerevisiae Mer1 KH domain is aligned to homologous KH domains in the proteomes of other fungal taxa—
Vanderwaltozyma polyspora (Vpo), Lachancea thermotolerans (Lth), Kluyveromyces lactis (Kla), Zygosaccharomyces rouxii (Zro), Debaryomyces
hansenii (Dha), and Pichia pastoris (Ppa)—and to the PCBP2 KH domain. The PCBP2 secondary structure elements are depicted below the
amino acid sequence. The RNA-binding side chains of PCBP2 and their counterparts in the fungal KH domains are highlighted in gray boxes;
the Mer1 residues subjected to mutational analysis are denoted by vertical line. Other positions of side chain identity/similarity in all eight proteins
are indicated by dot above the alignment. (B) Effects of Mer1 KH domain mutations on SPO22 and MER2 splicing. Splicing was gauged by RT–
PCR with MER2 or SPO22-speciﬁc primers using total RNA template isolated from wild-type haploids that had been transformed with 2m SPO22
plus a 2m plasmid for constitutive expression of wild-type Mer1 or the indicated Mer1 missense mutants, or with an empty 2mplasmid control ( ).
The splicing efﬁciencies are plotted. Each datum is the average of three separate experiments±SEM.
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RRM (RNA recognition motif) domains that are candi-
dates to mediate the imputed intron RNA-binding
function of Nam8. The mammalian TIA-1 protein—also
a triple RRM-containing polypeptide and a putative
homolog of yeast Nam8—has been shown to regulate
pre-mRNA splicing by binding to U-rich sequences
ﬂanking the 50 splice site (19). Thus, it is noteworthy
that the PCH2 intron contains two U-rich polypyrimidine
tracts: an 11-mer element (50-UUUUUUCUUU) immedi-
ately adjacent to the 50 splice site, and a 24-mer element
(50-UUCUUUUUCUUUCUUUCCUUCUUC) located
between the 50 splice site and the branchpoint (Figures 6
and S1). We considered that one or both of these PCH2
polypyrimidine tracts might act as Nam8 enhancers
(akin to the Mer1 enhancer discussed above) and
thereby be important for the observed Nam8-dependence
of PCH2 splicing. To test this idea, we deleted the
proximal or distal U-rich tracts en bloc from an otherwise
wild-type PCH2 transcript (retaining the long 50 exon and
deviant branchpoint) and assayed splicing efﬁciency of
these mutants pre-mRNAs (named UD1 and UD2 respect-
ively) in NAM8 and nam8Dyeast (Supplementary
Figure S1). Splicing of the UD1 transcript in NAM8 cells
(72%) was similar to that of the wild-type PCH2 RNA
(69%). Deleting the distal polypyrimidine tract in UD2
had a mild effect of splicing efﬁciency (56% in NAM8
cells) but did not alleviate Nam8 dependence, i.e. 18%
of the UD2 transcript was spliced in nam8cells
(Supplementary Figure S1). Splicing of mutant transcript
UD1+UD2, in which both U-tracts were deleted, was
similar to the UD2 single-deletant (Supplementary
Figure S1). These results exclude the idea that Nam8
promotes PCH2 splicing via obligate speciﬁc interactions
with one or both of the U-rich polypyrimidine element of
the PCH2 intron.
The PCH2 intron is a portable determinant of Nam8
dependence
We inserted the 113-nt PCH2 intron within the otherwise
intron-less chromosomal yeast HIS3 gene of NAM8 and
nam8 haploid yeast cells. The PCH2 intron was initially
placed near the 30 end of the HIS3 ORF (after nucleotide
+430) to reﬂect its distal position in the native PCH2
pre-mRNA (Figure 7A). HIS3 provides a convenient
reporter for gene expression, manifest as histidine
prototrophy. The native HIS3 gene is functional in
NAM8 and nam8strains, both of which grow on agar
medium lacking histidine (Figure 7B). By contrast, the
HIS3-[PCH2] gene containing the distally inserted
PCH2 intron was functional in NAM8 cells, but not in
the nam8Dbackground (Figure 7B). The salient ﬁnding
was that a single C-to-U mutation in the intron of the
HIS3-[PCH2] reporter that restored a consensus branch-
point (Figure 7A) sufﬁced to restore HIS3 function in
nam8cells (Figure 7B). These results show that the
PCH2 intron, by virtue of its deviant branchpoint, is an
autonomous determinant of Nam8-dependence in the
absence of other PCH2 gene elements (i.e. promoter, 50
and 30 exons, 50 and 30 untranslated regions). To evaluate
the contributions of 50 exon length to the
Nam8-dependence of PCH2 intron removal, we repos-
itioned the PCH2 intron proximally within the HIS3
reporter (inserting it at nucleotide +48). This maneuver
sufﬁced to allow nam8 cells to grow in the absence of
Figure 6. Determinants of the Nam8 dependence of PCH2 pre-mRNA splicing. The nucleotide sequence of the PCH2 intron is shown, highlighting
its nonconsensus branchpoint and the BP mutation that restored a consensus element. The sizes of the ﬂanking protein encoding 50 and 30 exons are
indicated. The 50 coding exon in the Dexon mutant was shortened to 51nt. The intronic C-to-U mutation (BP) that restored a consensus branchpoint
is illustrated. Splicing was gauged by RT–PCR with PCH2-speciﬁc primers using total RNA template isolated from wild-type (NAM8)o rnam8D
haploids that had been transformed with 2m PCH2 or its BP or Dexon mutant variants as speciﬁed. The splicing efﬁciencies are plotted. Each datum
is the average of three separate experiments±SEM.
Nucleic Acids Research,2011, Vol.39, No. 8 3437added histidine (data not shown). These results implicate
Nam8 in recognition and/or utilization of the
nonconsensus PCH2 branchpoint in the context of a
pre-mRNA substrate with a relatively long 50 exon.
Domain requirements for Nam8 function
The present ﬁndings that Nam8 governs two distinct
meiotic splicing pathways prompted us to demarcate the
functional domains of Nam8, about which virtually
nothing is known, and to gauge whether different
Nam8-dependent events rely on different structural
features of the Nam8 protein. Nam8 is a 523-aa polypep-
tide (Figure 8A) that includes three RRM domains
(Figure 8B). The closely spaced RRM1-RRM2 tandem
unit is preceded by a 40-aa N-terminal leader peptide
and separated from the downstream RRM3 domain
by a hydrophilic 63-aa inter-RRM linker peptide rich in
Ser (n=12), Asn (n=11) and Gln (n=8) (Figure 8A).
Distal to RRM3 is a hydrophilic 130-aa C-terminal exten-
sion that is also rich in Ser (n=17), Asn (n=18)
and Gln (n=15) (Figure 8A). Proteins with primary
structure similarity across the entire Nam8 polypeptide
can be found in the proteomes of other fungi, including
Neurospora crassa (491-aa), Kluyveromyces lactis (589-aa),
Candida glabrata (555-aa) and Ashbya gossypii (566-aa).
Many other fungi encode shorter proteins ( 400-aa) that
retain the three RRMs, but are missing the Nam8
C-terminal domain. An alignment of the primary struc-
tures of S. cerevisiae and A. gossypii Nam8 (Figure 8A)
helped guide the design of serial N and C terminal trun-
cations of S. cerevisiae Nam8 at the putative domain (or
subdomain) boundaries indicated by the forward and
reverse arrowheads in Figure 8A. The truncated open
reading frames were cloned into CEN plasmids under
the control of the native NAM8 promoter and tested for
function in vivo.
Because deletion of NAM8 has no apparent impact on
yeast growth at 18 Ct o3 7  C, we took advantage of syn-
thetic genetic interactions between nam8D and deletions of
other nonessential yeast genes implicated in pre-mRNA
splicing to assay for complementation of growth by the
Nam8 truncation mutants. For example, a nam8D
tgs1Dstrain that lacks Nam8 and Tgs1 (a nonessential
enzyme that synthesizes the trimethylguanosine cap
found on the U1, U2, U4 and U5 snRNAs) is slow
growing at 37 C, but inviable at  30 C (32). Growth of
nam8D tgs1D at 30 C was restored by a CEN plasmid
encoding full-length Nam8 (aa 1–523), whereas the
empty CEN vector was ineffective (Figure 8B). Deletion
of the N-terminal 40-aa leader peptide preceding RRM1
had no apparent impact on complementation of nam8D
tgs1D, nor did truncations at the C-terminus to positions
489 or 454 (Figure 8B). Moreover, simultaneous deletion
of aa 1–40 and 455–523 in NAM8-(41–454) also did not
affect complementation (Figure 8B), signifying that the
N and C terminal segments are dispensable. By contrast,
the next incremental C-terminal deletions, to positions
400 or 280, ablated nam8D tgs1D complementation
(Figure 8B). We conclude that: (i) Nam8-(1–400), which
contains all three RRMs, is not sufﬁcient for Nam8
activity in this genetic context and (ii) the Nam8
segment from aa 401–454 ﬂanking RRM3 is essential for
Nam8 activity. [Prior information on the C-terminus of
Nam8 was limited to the observation that a premature
stop codon at amino acid 140 eliminated Nam8 function
in a different synthetic lethal complementation assay (16).]
The effects of incremental N-terminal deletions that
serially removed the RRMs were also instructive.
Deletion of the entire RRM1 domain (in the 151–523
and 151–454 alleles) had little impact on nam8D tgs1D
complementation, signifying that RRM2 plus RRM3
sufﬁced for activity. However, deletions of both RRM1
and RRM2 (in the 251–523 and 251–454 alleles) resulted
in diminished complementation activity, as gauged by the
smaller size of NAM8-(251–523) tgs1D colonies vis a` vis
the preceding longer versions of Nam8 (Figure 8B).
Whereas further deletions into the inter-RRM linker did
not worsen Nam8 function (see 281–523 and 291–523),
complementation was abolished by truncating the N
terminus to aa 304 (Figure 8B), which is the predicted
proximal margin of the RRM3 domain (Figure 8A).
This result implicates the
291MSQFIYPVQQQPS
303
peptide ﬂanking RRM3 as important for Nam8 function
in this genetic assay; it is noteworthy that this peptide
sequence at the distal end of the inter-RRM linker is
well conserved in A. gossypii Nam8 (11/13 positions of
amino acid identity), whereas the rest of the linker is not
conserved (Figure 8A).
Figure 7. Installation of the PCH2 intron renders HIS3 expression
Nam8-dependent. (A) Schematic depiction of the HIS3 reporter
genes. The HIS3 ORF is shown in gray; the PCH2 introns are
colored black with the branchpoint sequence in the expanded view.
(B) Serial dilutions of isogenic NAM8 and nam8D cells harboring the
indicated chromosomal HIS3 cassettes were spotted in parallel on to
YPD agar medium (left) or synthetic drop-out medium lacking histi-
dine (right). The plates were incubated at 30 C and photographed after
2 days (YPD) or 3 days (–His).
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function varied with the genetic background in which
Nam8 becomes necessary for yeast growth, we performed
a parallel series of complementation assays in a nam8
lea1strain. A synthetic interaction of Nam8 and Lea1
(an inessential stable constituent of the U2 snRNP)
was detected in a recent genome-wide genetic array
analysis (41). A lea1D single mutant is temperature--
sensitive; it grows well at 20  to 34 C, but very slowly
at 37 C (32,42). Here, we constructed a nam8D lea1D
double mutant, which was synthetic lethal and required
plasmid p360-NAM8 (CEN URA3 NAM8) for viability
at 30 C (Supplementary Figure S2A). The nam8D lea1D
p360-NAM8 strain enabled us to test complementation by
plasmid shufﬂe. Cells transformed with a CEN LEU2
plasmid bearing full-length NAM8 plasmid grew on
medium containing FOA (a drug that selects against
the URA3 plasmid), while cells transformed with the
empty CEN LEU2 vector (or a vector encoding an
inactive Nam8 mutant) did not (Figure S2A). We found
that NAM8 truncation mutants 41–523, 151–523 and
1–454 permitted growth of ‘wild-type’ sized colonies on
FOA, while the 251–523, 281–523 and 291–523 alleles
yielded small colonies (data not shown). However, cells
transformed with mutants 304–523 or 1–400 did not
grow on FOA (data not shown). The viable strains
were grown in liquid medium and then spot-tested for
growth on YPD agar (Figure S2B). Deletion of the
N leader peptide plus RRM1 or the C-terminal domain
(aa 455–523) had little impact on cell growth per se,o ri n
combination (Supplementary Figure S3B). Further
N-terminal deletions of RRM2 and parts of the
inter-RRM linker resulted in slowed growth, e.g. reﬂected
in smaller colony size of the 291–523 and 251–454 strains
(Supplementary Figure S2B). We surmise that the domain
requirements for Nam8 function trend similarly in the
lea1 and tgs1 genetic backgrounds.
The synthetic genetic interactions of Nam8 also embrace
Mud1 (41), an inessential component of the U1 snRNP
(43). We constructed a nam8D mud1D strain bearing a
CEN URA3 NAM8 plasmid. Although this strain did
yield small FOA-resistant colonies under selection at
30 C when transformed with an empty CEN LEU2
plasmid (data not shown), the vector control cells grew
poorly on YPD agar (Supplementary Figure S3). By
contrast, transformation with a CEN LEU2 plasmid ex-
pressing full-length NAM8 resulted in normal-sized FOA-
resistant colonies and the cells derived from these colonies
grew well on YPD agar (Supplementary Figure S4, 1–523).
The salient ﬁndings were that the Nam8 RRM domain
requirements for complementation of nam8D mud1Dwere
less stringent than what we observed for nam8D tgs1D
and nam8D lea1D. To wit, Nam8-(291–523) and Nam8-
(291–454), which lack the leader, RRM1, RRM2 and
most of the inter-RRM linker, were as effective as
full-length Nam8 in supporting growth in the mud1Dback-
ground(SupplementaryFigureS3).Moreover,the304–523
mutant, which was inactive in the tgs1D and lea1D strains
(Figures 8B and S2), displayed weak complementation
activity in mud1D (Supplementary Figure S3).
Figure 8. Nam8 domain organization and requirements for complementation of nam8 tgs1.( A) The amino acid sequence of S. cerevisiae (Sce)
Nam8 from residues 28–523 is aligned to the sequence of A. gossypii (Ago) Nam8. Positions of amino acid site chain identity/similarity are denoted
by dot above the sequence. RNP2 and RNP1 motifs of the RRMs are indicated by brackets under the sequence. Forward and reverse arrowheads
indicate the boundaries of the N and C terminal truncations of Nam8, respectively. (B) (Top) Schematic representation of Nam8 domain organ-
ization; the RRMs are depicted as cylinders. (Bottom) CEN LEU2 plasmids bearing wild-type NAM8 (denoted as 1–523) or the indicated deletants
were tested by plasmid shufﬂe for nam8D tgs1D complementation. nam8D tgs1D p360-TGS1 (URA3 CEN TGS1) cells were transformed with the
CEN LEU2 NAM8 plasmids or the empty CEN LEU2 vector. Individual Leu
+transformants were counterselected for growth on FOA agar medium
at 37 C. FOA-resistant colonies were patched on SD-Leu agar medium at 37 C. The strains were then grown in liquid culture in SD-Leu medium at
37 C; the cultures were diluted with water to attain an A600 of 0.1 and then aliquots (3ml) of serial 10-fold dilutions (in water) were spotted on YPD
agar plates. The plates were photographed after 3 days at 30 C.
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activity in complementation in the synthetic lethal nam8D
mud2D background (44). Mud2 is an inessential
RRM-containing protein that forms a stable complex
with the yeast branchpoint binding protein (BBP) that
recruits the U2 snRNP during spliceosome assembly
(45,46). We constructed a nam8D mud2D double-mutant,
which required either plasmid p360-MUD2 (CEN URA3
MUD2) or p360-NAM8 (CEN URA3 NAM8) for viability
(Figure S4A). Growth of these strains on FOA agar was
allowed after transformation with CEN LEU2 plasmids
bearing either MUD2 or NAM8, but not after transform-
ation with the empty CEN LEU2 vector (Supplementary
Figure S4A). We found that NAM8 N-terminal truncation
mutants 41–523, 151–523, 251–523 and 281–523 permitted
growth of nam8D mud2Dcells on FOA, whereas mutants
291–523 and 304–523 did not (data not shown). The viable
NAM8 N-deletants were grown in liquid medium and then
spot-tested for growth on YPD agar (Supplementary
Figure S4B). These results indicate that the leader,
RRM1, and RRM2 are dispensable for Nam8 function
in the mud2background, though the distal part of the
inter-RRM linker is essential. The C-terminal deletant
1–454 supported normal growth in the mud2back-
ground (Supplementary Figure S4B), but the 1–400
mutant was lethal (no growth on FOA; not shown).
Simultaneous deletion of aa 1–40 and 455–523 in
NAM8-(41–454) did not affect complementation of
nam8D mud2D (Supplementary Figure S4B). However,
combining the RRM1 deletion with the C-terminal trun-
cation clearly weakened NAM8-(151–454) function in the
mud2 background (Supplementary Figure S4B).
Finally, we tested Nam8 function in a different genetic
assay predicated on the growth-inhibitory effects of Nam8
overexpression (47). NAM8 and truncated versions
thereof were installed on 2m URA3 plasmids under the
control of a galactose-inducible promoter. The plasmids
were introduced into wild-type cells, which were then
tested for growth on –Ura medium containing either
glucose (NAM8 expression repressed) or galactose
(NAM8 expression induced). Whereas all of the strains
grew normally on glucose, the galactose-induced expres-
sion of full-length Nam8 from the 2mplasmids inhibited
colony formation, an effect not seen with the empty 2m
vector (Supplementary Figure S5). Galactose-dependent
growth inhibition was evident for the single N- and
C-terminal truncations that scored as active in the synthet-
ic lethal complementation assays: 41–523, 151–523, 1–489
and 1–454, again attesting the dispensability of the leader,
RRM1, and C-terminal segment (Supplementary
Figure S5). The more extensively truncated versions of
NAM8 that were inactive in the complementation assays
(1–400, 1–280 and 304–523) had little or no effect on
growth when induced by galactose at high gene dosage.
Between these extremes, we saw that N-terminal deletions
embracing RRM2 (251–523 and 281–523) alleviated the
inhibitory effects of galactose induction, albeit not com-
pletely (Supplementary Figure S5). The enfeebled
dominant negative activity of the RRM2 deletants was
consistent with their weakened complementation activity
in the tgs1D and lea1D backgrounds.
Nam8 domain requirements for splicing of SPO22 and
PCH2 pre-mRNAs
The full-length and truncated NAM8 alleles were tested in
nam8haploids for their activities in Mer1-dependent
splicing of the MER2 pre-mRNA (Figure 9A) and
Mer1-independent splicing of PCH2 pre-mRNA
(Figure 9B). MER2 splicing efﬁciency was unaffected by
loss of the N-terminal leader and C-terminal tail segments,
singly or in combination (Figure 9A). Deletion of RRM1
had little impact  66% MER2 splicing efﬁciency in
NAM8-(151–523) cells versus 77% in NAM8-(41–523)
cells. However, deletion of RRM1 and RRM2 sharply
reduced MER2 splicing efﬁciency—to 13% in NAM8-
(251–523) cells, a level barely above the 7% splicing
seen in the nam8D strain (Figure 9A). A C-terminal
deletion of the segment from aa 401–454 abolished
MER2 splicing (Figure 9A). Thus, the domain require-
ments for MER2 splicing in the presence of Mer1 reﬂect
the trends seen for complementation of nam8D tgs1D (and
are apparently more demanding than those for
Nam8-dependent vegetative growth in mud1 and
mud2 backgrounds).
The effects of Nam8 domain deletions on PCH2
pre-mRNA splicing (Figure 9B) were qualitatively
similar to those for MER2 splicing, although the incre-
mental removal of RRM2 caused a larger reduction in
PCH2 splicing—42% in NAM8-(151–523) cells versus
62% in NAM8-(41–523) cells and 21% in the nam8D
controls.
Targeted mutations in Nam8 RRM2 and RRM3 guided
by the structure of TIA-1
The RRM fold comprises a four-stranded b-sheet ﬂanked
on one side by two a-helices, as exempliﬁed in the crystal
structure of the RRM2 domain of human TIA-1 (48)
(Figure 10A), the putative homolog of the Nam8 RRM2
domain, to which it aligns with 43/80 positions of amino
acid identity/similarity (Figure 10B). RRM domains typ-
ically bind RNA along the exposed surface of the b-sheet
opposite the a-helices (49). The central b1 and b3 strands
of the sheet (referred to as the RNP2 and RNP1 motifs,
respectively, and denoted by brackets under the Nam8
primary structure in Figure 8A) make most of the
atomic contacts with bound RNA.
The present ﬁndings that interval deletions of RRM2
plus RRM3 abolished all Nam8 activities prompted us to
test the effects of alanine mutations in the putative
RNA-binding surfaces of RRM2 and RRM3. The
alanine changes were introduced into Nam8-(41–454), a
biologically active allele that includes all three tandem
RRMs, and the mutants were assayed for complementa-
tion of the nam8Dtgs1Dstrain. With respect to RRM2, we
tested a single-alanine substitution at Phe166 in the b1
strand RNP2 motif and a triple alanine substitution for
Lys205, Tyr207 and Phe209 in the b3 strand RNP1 motif;
these side chains project outward on the surface of the
b-sheet opposite the two a-helices (Figure 10A) and
would correspond to residues in canonical RRMs that
interact with RNA. We also combined the RNP2 and
RNP1 mutations to generate a quadruple-alanine cluster
3440 Nucleic Acids Research, 2011,Vol.39, No. 8allele, F166A-K205A-Y207A-F209A. The F166A change
per se had little effect on Nam8 function in this assay, as
gauged by colony size; however, the triple RNP1 mutant
and the quadruple mutant resulted in slowed growth and
tiny colonies (Figure 10C), similar to the effects of deleting
the RRM2 domain on Nam8 function in the tgs1Dback-
ground (Figure 8B, 251–454).
In RRM3, we introduced a single-alanine substitution
at Phe316 in the b1 strand and a double-alanine substitu-
tion for Lys348, and Phe352 in the b3 strand; also we
combined these to make a triple mutant,
F316A-K348A-F352A. Here, the double RNP1 mutant
and the combined RNP2/RNP1 triple mutant were ex-
tremely sick (Figure 10C), attesting to a critical contribu-
tion of RRM3, and its putative RNA-binding surface, to
Nam8 activity when RRMs 1 and 2 are present.
The effects of the RRM mutations on Nam8-dependent
splicing of MER2 pre-mRNA were gauged by transform-
ing nam8D haploids constitutively expressing Mer1 with
CEN plasmids bearing the ‘wild-type’ or alanine-
substituted NAM8-(41–454) alleles. Subtraction of the
side chains at the putative RNA binding surface of the
RRM2 and RRM3 domains reduced MER2 splicing to
background levels (Figure 10C).
DISCUSSION
Regulated meiotic splicing in budding yeast is an elegant
example of a post-transcriptional ‘off–on’ switch linked to
a developmental program. Whereas only  5% of yeast
genes contain introns, there is an evident enrichment for
introns among the genes encoding meiosis-speciﬁc
proteins, and a tendency for meiotic introns to bear
splicing signals that deviate from the norm (31,38). It
has been suggested that upregulation of splicing during
meiosis—via programmed transition from the splicing
‘off’ state during vegetative growth—provides added pro-
tection against the untimely production of meiotic
proteins that could be deleterious to vegetative cells
(11,31). Prior studies had characterized a single meiotic
splicing regulon controlled by Mer1 and Nam8 and
embracing three pre-mRNA targets. The regulatory
inputs (if any) to the splicing of the other known
meiosis-speciﬁc pre-mRNAs are a virtual tabula rasa
(31). Here, by surveying the full catalogue of
meiosis-speciﬁc spliced pre-mRNAs for their dependence
on Nam8, we’ve expanded the scope of the Mer1/Nam8
regulon to embrace SPO22 and illuminated a novel
Mer1-independent role for Nam8 in splicing of PCH2
pre-mRNA. The two ﬂavors of Nam8-dependent
splicing differ fundamentally. The Mer1/Nam8-regulated
meiotic transcripts share two properties: (i) they have an
intronic enhancer sequence, to which Mer1 is thought to
bind via its KH domain and (ii) they have non-consensus
50 splice sites. By contrast, the PCH2 transcript lacks a
Mer1 intronic enhancer and contains a perfect 50 splice
site.
We focused here on dissecting the contributions of the
Mer1 enhancer sequence, Mer1 KH domain, and other
SPO22 intronic signals to splicing of SPO22
pre-mRNA, the newly identiﬁed Nam8 target. Whereas
SPO22 has multiple potentially enfeebling non-consensus
intronic signals (50SS, BP and 30SS), we ﬁnd that the
atypical 50SS is the decisive factor in Nam8/Mer1 depend-
ence, insofar as a single nucleotide change in the SPO22
intron that restores a consensus 50SS overrides the require-
ments for Mer1 and Nam8. The same scenario applies to
the MER3 intron.
Our studies of PCH2 splicing implicate the
non-consensus 50-CACUAAC branchpoint and the excep-
tionally long 50 exon as separable negative inﬂuences on
PCH2 splicing in wild-type cells and as concerted deter-
minants of Nam8-dependence. The ﬁnding that
Nam8-dependence is portable with the PCH2 intron,
when inserted into the HIS3 reporter, certiﬁes the import-
ance of the intron and its deviant branchpoint as decisive
elements per se in the Nam8 requirement. The action of
Nam8 in countering a suboptimal PCH2 branchpoint in
the context of a perfect 50 splice site differs from the case
of Mer1/Nam8-dependent splicing, where the intron-
bound Mer1 facilitates recruitment of the Nam8-
containing U1 snRNP to a suboptimal 50 splice site
Figure 9. Nam8 domain requirements for splicing of MER2 and PCH2
pre-mRNAs. (A) Splicing was gauged by RT–PCR with MER2-speciﬁc
primers using total RNA template isolated from nam8 haploids that
had been transformed with the indicated CEN NAM8 plasmids plus a
2m plasmid for constitutive expression of wild-type Mer1. (B) Splicing
was gauged by RT–PCR with PCH2-speciﬁc primers using total RNA
template isolated from nam8 haploids that had been transformed with
the indicated CEN NAM8 plasmids plus a 2m PCH2 plasmid. The
splicing efﬁciencies are plotted. Each datum is the average of three
separate experiments±SEM.
Nucleic Acids Research,2011, Vol.39, No. 8 3441(14,15,26) (Figure 11A). Current models invoke bridging
contacts between U1 snRNP components Nam8, Snu56
and Snu71 with the enhancer-bound Mer1 in mediating
U1 recruitment to the deviant 50 splice site (22,26)
(Figure 11A). We speculate that Nam8 facilitates PCH2
splicing via macromolecular interactions that recruit the
U2 snRNP to the deviant branchpoint (Figure 11B). The
participants in this putative interaction network remain to
Figure 10. Targeted mutations in the Nam8 RRM domains guided by the structure of TIA-1. (A) Stereo view of the crystal structure of the RRM2
domain of TIA-1 (pdb id: 3BS9). The side chains at the putative RNA-binding surface are shown as stick models. (B) The amino acid sequences of
the Nam8 and TIA-1 RRM2 domains are aligned. The TIA-1 secondary structure elements are depicted below the amino acid sequence. The putative
Nam8 RNA-binding residues subjected to mutational analysis are denoted by vertical line. Other positions of side chain identity/similarity are
indicated by dot above the alignment. (C) The indicated versions of Nam8-(41–454) were tested for complementation of nam8D tgs1D as described in
Figure 8. Serial dilutions of liquid cultures were spotted on YPD agar; the plates were photographed after 3 days at 30 C. Mutational effects on
splicing were gauged by RT–PCR with MER2-speciﬁc primers using total RNA template isolated from nam8 haploids that had been transformed
with the indicated CEN NAM8-(41–454) plasmids plus a 2m plasmid for constitutive expression of wild-type Mer1. The splicing efﬁciencies are
shown. Each datum is the average of three separate experiments±SEM.
3442 Nucleic Acids Research, 2011,Vol.39, No. 8be identiﬁed. Toward that end, the Nam8-responsive
HIS3-[PCH2] reporter that we developed here may
prove useful in forward genetic screening for yeast
mutants that either lose their His prototrophy in NAM8
cells (as candidate cofactors for Nam8-dependent splicing)
or mutants that acquire His prototrophy in nam8cells
(as candidate suppressors of Nam8-dependency).
The present study illuminates a ﬁrst set of instructive
structure–function relations for the yeast Nam8 protein.
As depicted in Figures 8 and 11, Nam8 consists of three
RRM domains ﬂanked by N-terminal ‘leader’ and
C-terminal ‘trailer’ segments. Whereas the distal segment
of the trailer domain (aa 455–523) is unnecessary for any
Nam8 activity surveyed, our results demonstrate an essen-
tial contribution by the proximal part of the Nam8
C-terminal domain (aa 401–454) in all aspects of Nam8
function. One or more of the RRMs are plausible candi-
dates for the imputed intron RNA-binding properties of
Nam8. Here, we showed that the N leader and RRM1 are
dispensable for Nam8-dependent splicing of meiotic
pre-mRNA targets and for Nam8 function in vegetative
yeast growth in a variety of synthetic genetic backgrounds.
Thus, RRM1 is not implicated in Nam80s principal
contacts to RNA or other components of the splicing
apparatus.
Deleting RRM2 along with RRM1 resulted in:
(i) disabled Nam8-dependent splicing of MER2 and
PCH2 pre-mRNAs; (ii) variable effects, ranging from
loss of activity to no impact, on Nam8-dependent
growth, according to the genetic background being
assayed. Because it is possible that RRM1 and RRM2
are functionally redundant, we made an independent test
of RRM2 function by targeting alanine substitutions to
the putative RNA-binding surface of RRM2 in the
context of an otherwise active Nam8 protein that
contains all three RRMs. The decrements in vegetative
growth in the tgs1background and in splicing of
MER2 pre-mRNA implicated RRM2 as a direct partici-
pant in Nam8 activity. Nakagawa and Ogawa (21)
reported previously that a single mutation, Leu170Pro,
in the RNP2 motif (IFVGDL
170) of Nam80s RRM2
domain resulted in a severe defect in meiotic recombin-
ation, comparable to that of a nam8null. However, we
deem this mutational effect as poorly instructive with
regard to RRM function, because reference to the equiva-
lent VFVGDL motif in the TIA-1 RRM2 crystal structure
(Figure 10B) shows us that the Leu170 side chain is not
projecting outward onto the putative RNA-binding
surface, but rather points into the hydrophobic core of
the RRM (data not shown). Thus, a proline change at
this position would be more likely to impact the folding
of the RRM2 module than to speciﬁcally affect an
RNA-binding site.
Extending the N-terminal deletions to the proximal
margin of RRM3 (aa 304) abolished or severely
weakened all of the Nam8 functions tested. As mentioned
above, we attempted to isolate RRM30s contributions by
making alanine changes in the predicted RRM3
RNA-binding surface. The severe defects in vegetative
growth in the tgs1background and in splicing of
MER2 pre-mRNA caused by the RRM3 alanine clusters
implicated RRM3, too, as important for Nam8 activity.
Although the results are consistent with an RNA-binding
role for either RRM2 or RRM3, it is plausible that one
(or both) of the Nam8 RRMs mediates important
protein–protein interactions, rather than RNA binding,
as has been described for other RRM domains (50).
It is interesting to note that the least demanding genetic
function of Nam8 is seen in the mud1background, where
Nam8-(291–454)—which lacks RRMs 1 and 2—sufﬁces
for normal growth. Mud1, like Nam8, is an intrinsic
protein component of the yeast U1 snRNP. We presume
that the synthetic growth phenotype of the nam8D
mud1Ddouble-mutant reﬂects a gross defect in U1
snRNP structure and function, in which case its full com-
plementation by Nam8-(291–454) implies that this
minimized version of Nam8 is assimilated into the U1
snRNP lacking Mud1 and renders it active. That Nam8-
(291–454) is not adept at (i) splicing Nam8 meiotic targets
with suboptimal introns; (ii) complementing yeast synthet-
ic lethal interactions with splicing factors that are not U1
snRNP components (Lea1, Mud2, Tgs1); or (iii) inhibiting
vegetative growth when overexpressed suggests that
upstream domains (i.e. RRM2 and the interdomain
linker) mediate the invoked interactions of Nam8 with
non-U1 splicing factors or the pre-mRNA.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
Figure 11. Two modes of Nam8-dependent splicing. (A) The Mer1/
Nam8 co-dependent splicing regulon embraces four meiotic
pre-mRNAs with weak non-consensus 50 splice sites (50-SS*). Efﬁcient
splicing is achieved when Mer1, bound to an intronic enhancer
sequence ﬂanking the 50-SS*, facilitates recruitment of the
Nam8-containing U1 snRNP via proposed Mer1 interactions with U1
proteins Snu56 and Snu71. (B) A novel Nam8 splicing regulon, which is
independent of Mer1, is deﬁned by the meiotic PCH2 transcript. The
PCH2 intron has a nonconsensus branchpoint (BP*) that relies on
Nam8 for efﬁcient splicing. Because PCH2 has a consensus 50-SS, we
surmise that Nam8 action in this regulon entails enhanced recruitment
of the U2 snRNP to BP*. This step could involve physical interactions
(direct or indirect) between Nam8 and the U2 snRNP (or the
branchpoint-binding protein Msl5).
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